Jagsonpal Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jagsonpal Pharmaceuticals has published a notice in Business Standard (English and Hindi) on April 14, 2026, informing shareholders about an upcoming transfer of shares to the Investor Education and Protection Fund (IEPF) Authority. The transfer applies to shareholders who have not claimed their dividend for seven consecutive years, as required under Section 124(6) of the Companies Act, 2013. Individual notices were already dispatched to affected shareholders on April 11, 2026, and full details have been uploaded to the company's website (www.jagsonpal.com). Shareholders have until July 10, 2026, to claim their shares, failing which the company will transfer them to the IEPF Authority without further notice.
This is a routine compliance filing, but shareholders who have unclaimed dividends for 7 or more consecutive years should verify their holdings and update their KYC details immediately. Affected shareholders risk losing their shares if they do not act before the July 10, 2026 deadline, though shares transferred to IEPF can still be claimed back later by following the prescribed procedure.